Le Lézard
Classified in: Transportation, Covid-19 virus

Aircraft Thrust Reverser Actuation Systems Global Market Report 2022: Stringent Safety Regulations Drive the Importance of Redundant Aircraft Systems Including Thrust Reversers - ResearchAndMarkets.com


The "Aircraft Thrust Reverser Actuation Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Aircraft Thrust Reverser Actuation Systems Market to Reach $1.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Aircraft Thrust Reverser Actuation Systems estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$1.7 Billion by 2030, growing at a CAGR of 2.3% over the analysis period 2022-2030. Commercial Aircraft, one of the segments analyzed in the report, is projected to record a 2.6% CAGR and reach US$916.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Business Jets segment is readjusted to a revised 2.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $375.5 Million, While China is Forecast to Grow at 4% CAGR

The Aircraft Thrust Reverser Actuation Systems market in the U.S. is estimated at US$375.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$316.3 Million by the year 2030 trailing a CAGR of 4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 2.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$207.5 Million by the year 2030.

Select Competitors (Total 46 Featured) -

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

A selection of companies mentioned in this report includes

For more information about this report visit https://www.researchandmarkets.com/r/927om8-thrust?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

24 avr 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

24 avr 2024
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

24 avr 2024
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...



News published on and distributed by: